Clinical trial
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and…
NCT00261924 · Cerus Corporation, Industry · Completed
Key facts
| NCT number | NCT00261924 |
|---|---|
| Title | Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days |
| Official title | Clinical Trial to Evaluate the Therapeutic Efficacy and Safety of INTERCEPT Platelets Stored for up to Seven Days After Collection |
| Acronym | TESSI |
| Lead sponsor | Cerus Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thrombocytopenia |
| Intervention type | Device |
| Interventions | Transfusion of Pathogen Inactivated Platelets stored for 6-7 days |
| Enrollment | 211 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Dec 6, 2005 |
| Last update posted | Apr 14, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: